SCHEMBL7306133

SCHEMBL7306133

Oc1c(C(Cl)Cl)cccc1C(Cl)Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 6/20 0.55
TSHR P16473 5/20 0.55
CA2 P00918 4/20 0.55
GABRB2 P47870 4/20 0.55
LMNA P02545 3/20 0.55
CYP3A4 P08684 3/20 0.55
CA1 P00915 2/20 0.55
HPGD P15428 2/20 0.55
GABRB1 P18505 2/20 0.55
GABRG2 P18507 2/20 0.55
GABRB3 P28472 2/20 0.55
CYP1A2 P05177 2/20 0.55
FAAH O00519 1/20 0.55
PTGS1 P23219 1/20 0.55
SLC6A2 P23975 1/20 0.55
HTR2C P28335 1/20 0.55
GABRA5 P31644 1/20 0.55
GABRA3 P34903 1/20 0.55
HTR2B P41595 1/20 0.55
GABRA2 P47869 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589720 0.87 ALDH1A1 (0.52) GABRA1TSHRCA2GABRB2LMNA
SCHEMBL9721055 0.78 GABRA1 (0.64) GABRA1TSHRCA2GABRB2LMNA
SCHEMBL8644420 0.75 GPR35 (0.64) TSHRLMNACYP3A4HPGDCYP1A2
SCHEMBL565882 0.74 GABRA1 (0.56) GABRA1TSHRCA2GABRB2LMNA
SCHEMBL3785333 0.74 TSHR (0.50) GABRA1TSHRCA2GABRB2LMNA
SCHEMBL5589726 0.73 CYP2D6 (0.34) GABRA1TSHRCA2GABRB2LMNA
SCHEMBL7306128 0.73 TSHR (0.36) GABRA1TSHRCA2GABRB2LMNA
SCHEMBL6820234 0.73 CYP1A2 (0.45) GABRA1TSHRCA2GABRB2LMNA
SCHEMBL9720918 0.72 GABRA1 (0.50) GABRA1TSHRCA2GABRB2LMNA
SCHEMBL7304304 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed
EP-0025659-B1 PROCESSES FOR THE PRODUCTION OF 1,2,3-TRIHYDROXYPHENYL COMPOUNDS FBC LIMITED (GB) 1983-11-02 EP disclosed
US-4351968-A Production of organic compounds FBC LIMITED (GB) 1982-09-28 US disclosed
EP-0025659-A2 Processes for the production of 1,2,3-trihydroxyphenyl compounds FBC LIMITED (GB) 1981-03-25 EP disclosed